|

ALN-4324 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Alnylam Pharmaceuticals2

Indications

  • Type 2 Diabetes Mellitus (T2DM)2
  • Diabetes2
  • Obese or Overweight Healthy Volunteers1

Chula Vista, California1 trial

A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus

Clinical Trial Site

Phase 2

Miami, Florida1 trial

A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM

Clinical Trial Site

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.